about
Macrophages: master regulators of inflammation and fibrosis.Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury.Is YKL-40 a new therapeutic target in cancer?Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.Human chitinases and chitinase-like proteins as indicators for inflammation and cancerYKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Pronounced inflammatory response to endotoxaemia during nighttime: a randomised cross-over trial.Plasma YKL-40: a potential new cancer biomarker?YKL-40: a new biomarker in cardiovascular disease?YKL-40 expression in CD14⁺ liver cells in acute and chronic injury.The Effects of Quercetin on Acute Lung Injury and Biomarkers of Inflammation and Oxidative Stress in the Rat Model of Sepsis.Attenuation of sepsis-induced organ injury in mice by vitamin C.Lower limb ischaemia and reperfusion injury in healthy volunteers measured by oxidative and inflammatory biomarkers.High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality.
P2860
Q34076279-7087664E-A717-42C4-B923-78186AC12E9EQ35647254-B804B0E0-4E15-4AA0-A50C-A4F8BF767944Q36209083-F16D5B68-7920-4522-9A0F-AC3D0F60705EQ36709555-06154A50-E8D9-47B9-A0B7-60548B2DC68FQ36731284-E0B29E84-E6B4-468C-B8AF-B74F8B7CD94EQ37073992-86454C62-8A0F-4A43-9064-4C4734D0322BQ37280948-43D62B5D-A7EB-4803-9F49-D6762E764BBBQ37334247-1405E801-4B0A-4338-91C2-5335C1C6C575Q37521425-3C79D761-470C-457F-9F23-34935FF27296Q37605869-EC38CCA3-69E3-4671-890E-EC0FDCFE9236Q37779310-1E0B24FA-38D4-4C36-B478-EDD5B9ECBB3EQ38576425-09E329AC-6F76-4E4D-9485-2CBA44D8E445Q40870275-41EA1142-7D9D-45A0-91C3-D0C94DF38D47Q44208591-74FDCED2-CC75-4BEC-8B1F-8B9B36B97594Q46907080-7A6F2F5B-CC9A-4429-B932-C958D59FE4D6Q53511677-BDD4925F-7BF8-4084-BEB1-9AFD922A679F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Circulating YKL-40 levels during human endotoxaemia.
@en
Circulating YKL-40 levels during human endotoxaemia.
@nl
type
label
Circulating YKL-40 levels during human endotoxaemia.
@en
Circulating YKL-40 levels during human endotoxaemia.
@nl
prefLabel
Circulating YKL-40 levels during human endotoxaemia.
@en
Circulating YKL-40 levels during human endotoxaemia.
@nl
P2860
P1476
Circulating YKL-40 levels during human endotoxaemia.
@en
P2093
J S Johansen
K S Krabbe
P2860
P304
P356
10.1111/J.1365-2249.2005.02763.X
P577
2005-05-01T00:00:00Z